The influence of passage number and different culture conditions on the effect of ATP and angiotensin II (A II) on membrane voltage (Vm) of rat mesangial cells (MC) was examined with the patch clamp technique in slow and fast whole cell recordings. MC were characterized immunologically and grown in standard medium in primary culture (PC) and long-term culture up to passage 21 in the presence of 90 g/l fetal calf serum (LTC/ +FCS) or without or with 5 g/l FCS for 1-3 days (LTC/-FCS). In all three series the studies were performed in a FCS-free Ringer-like solution. Vm of MC did not differ in the series (PC: -49 ± lmV, n = 151; LTC/+FCS: -52 ± 1 mV, n = 49; LTC/-FCS: -51 ± 1 mV, n = 44). In primary culture and long-term cultured MC up to passage 8, FCS (ED50≈5 g/l), ATP (ED50 ≈ 2 × 10-6 mol/l) and AII (ED50 ≈ 5 × 10-10 mol/l) induced a depolarization of Vm. Reduction of extracellular Cl- concentration (from 145 to 32 mmol/l) had no effect on Vm but led to an increased depolarization of Vm by FCS, ATP and A II. In long-term cultured MC above passage 8 grown with 90 g/l FCS both ATP and AII induced a concentration-dependent hyperpolarization of Vm, which was attenuated in increased extracellular K+ concentration (from 3.6 to 33.6 mmol/l). In long-term cultured MC beyond passage 8, grown without or with a reduced FCS concentration of 5 g/l, ATP and A II led to a transient depolarization of Vm, which was increased in the presence of 32 mmol/l extracellular Cl-. The depolarization was followed by a hyperpolarization, which was attenuated in the presence of increased extracellular K+. The data indicate that vasoactive agents depolarize Vm of MC in primary culture by activating a Cl- conductance whereas they hyperpolarize Vm by activation of a K+ conductance in long-term cultured MC grown with FCS. The latter effect was partially reversed when FCS was omitted.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.